Related news from
Thu, 06 Nov 2025 21:45:40 +0000	Cencora makes $1 billion investment in pharma supply chains Cencora is betting on the future of pharmaceutical logistics, announcing a $1 billion investment through 2030 to expand and modernize its U.S. distribution infrastructure. This move is not just network growth, but a shift aimed at supporting the rising demand of prescription medications and strengthening the reliability of the supply chain that delivers them. The […] The post Cencora makes $1 billion investment in pharma supply chains appeared first on FreightWaves.
Thu, 06 Nov 2025 11:21:22 +0000	Cencora to invest $1bn in US pharma distribution network The second national distribution centre, which is in Harrison, Ohio, will be operational by spring 2027.
Thu, 06 Nov 2025 08:16:20 +0000	Cencora (COR): $713 Million One-Off Loss Challenges Bull Case on Margin Recovery Cencora (COR) posted a net profit margin of 0.6%, a notch below last year’s 0.7%, while earnings rose 2.2% in the latest period, a significant slowdown from its 48.8% average annual growth rate over the past five years. Looking ahead, analysts expect earnings to increase by 11.04% per year, trailing the broader US market’s 16%, with the top line forecast to grow 6.7% versus the market’s 10.5%. However, the results were overshadowed by a one-off loss of $713.2 million in the trailing 12 months...
Thu, 06 Nov 2025 05:34:31 +0000	COR Q3 Deep Dive: Specialty Expansion and Portfolio Restructuring Drive Strategic Focus Healthcare distributor Cencora (NYSE:COR) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 5.9% year on year to $83.73 billion. Its non-GAAP profit of $3.84 per share was 1.4% above analysts’ consensus estimates.
Wed, 05 Nov 2025 21:00:34 +0000	Cencora Inc (COR) Q4 2025 Earnings Call Highlights: Strategic Investments Propel Growth Amid ... Cencora Inc (COR) reports robust growth in adjusted income and EPS, while navigating goodwill impairments and strategic realignments.
Wed, 05 Nov 2025 16:54:00 +0000	Rigetti Computing to Post Q3 Earnings: What's in Store for the Stock? RGTI's Q3 results are likely to gain from U.S. funding clarity, new contracts and gains from its next-gen quantum system.
Wed, 05 Nov 2025 15:56:00 +0000	COR Q4 Earnings & Revenues Beat Estimates, Gross Margin Improves Cencora's Q4 results top estimates with 15% EPS growth and stronger margins, as GLP-1 demand and the RCA acquisition fuel solid segment gains.
Wed, 05 Nov 2025 15:06:14 +0000	Cencora (COR) Q4 2025 Earnings Call Transcript Bennett S. Murphy: Thank you. Good morning, good afternoon, and thank you for joining us for this conference call to discuss Cencora, Inc.'s fiscal 2025 fourth quarter and full year results. Joining me today are Robert P. Mauch, President and CEO, and James F. Cleary, Executive Vice President and CFO.
Wed, 05 Nov 2025 14:30:10 +0000	Cencora (COR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Cencora (COR) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Wed, 05 Nov 2025 12:40:01 +0000	Cencora (COR) Q4 Earnings and Revenues Surpass Estimates Cencora (COR) delivered earnings and revenue surprises of +1.32% and +0.69%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Wed, 05 Nov 2025 12:00:00 +0000	Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain The company will open two new distribution centers and expand a third as demand surges for GLP-1s and other refrigerated medications.
Wed, 05 Nov 2025 12:00:00 +0000	Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network CONSHOHOCKEN, Pa., November 05, 2025--Cencora, a global pharmaceutical solutions company, today announced plans to invest $1 billion through 2030 to bolster and expand its pharmaceutical distribution network in the United States. The investments — headlined by the opening of its second national distribution center in Ohio and an expanded presence in Alabama and California — will increase Cencora’s capacity, improve efficiency and enhance the resilience of its national distribution network, stren
Wed, 05 Nov 2025 11:44:39 +0000	Cencora’s (NYSE:COR) Q3 Sales Top Estimates Healthcare distributor Cencora (NYSE:COR) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.9% year on year to $83.73 billion. Its non-GAAP profit of $3.84 per share was 1.4% above analysts’ consensus estimates.
Wed, 05 Nov 2025 11:39:38 +0000	Cencora: Fiscal Q4 Earnings Snapshot CONSHOHOCKEN, Pa. AP) — Cencora, Inc. COR) on Wednesday reported a loss of $339.7 million in its fiscal fourth quarter.
Wed, 05 Nov 2025 11:30:00 +0000	Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results CONSHOHOCKEN, Pa., November 05, 2025--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2025 fourth quarter ended September 30, 2025, revenue increased 5.9 percent to $83.7 billion. Revenue increased 9.3 percent to $321.3 billion for fiscal year 2025. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $(1.75) for the September quarter of fiscal 2025, compared to $0.02 in the prior year quarter. Adjusted diluted EPS, which is
Tue, 04 Nov 2025 23:35:02 +0000	Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates Agilon (AGL) delivered earnings and revenue surprises of -50.00% and +0.57%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Tue, 04 Nov 2025 13:39:00 +0000	Solventum to Post Q3 Earnings: Is a Beat Likely for the Stock? Solventum's Q3 results may reflect softer sales and tariff impacts, though pricing discipline and core growth drivers likely aided margins.
Tue, 04 Nov 2025 13:39:00 +0000	DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock? Dentsply Sirona's Q3 results may reveal ongoing softness in U.S. demand and orthodontic segments despite steady cost control.
Tue, 04 Nov 2025 13:38:00 +0000	Will Strong Segmental Performance Drive MCK's Top Line in Q2? McKesson's Q2 results may show steadier growth as strong U.S. pharmaceutical and RxTS momentum drive its expanding top line.
Tue, 04 Nov 2025 03:11:19 +0000	Earnings To Watch: Cencora (COR) Reports Q3 Results Tomorrow Healthcare distributor Cencora (NYSE:COR) will be reporting earnings this Wednesday before the bell. Here’s what you need to know.

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!